ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
XOMA Royalty Corporation

XOMA Royalty Corporation (XOMAO)

25,30
-0,06
(-0,236593%)
À la fermeture: 04 Février 10:00PM
25,30
0,00
( 0,00% )
Après les heures de négociation: 10:02PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
25,30
Prix Achat
25,10
Prix Vente
25,40
Volume échangé
1 396
25,26 Fourchette du Jour 25,37
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
25,36
Ouverture
25,37
Dernière Transaction
100
@
25.3
Dernière heure de transaction
22:00:00
Volume financier
US$ 35 376
VWAP
25,34
Volume moyen (3 m)
-
Actions en circulation
11 782 723
Rendement du Dividende
8.28%
Ratio Cours sur Bénéfices
-7,35
Bénéfice par action (BPA)
-3,47
Chiffre d'affairess
4,76M
Bénéfice net
-40,83M

À propos de XOMA Royalty Corporation

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
XOMA Royalty Corporation est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker XOMAO. Le dernier cours de clôture d'XOMA Royalty était de US$25,36. Au cours de la dernière année, les actions de XOMA Royalty ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

XOMA Royalty compte actuellement 11 782 723 actions en circulation. La capitalisation boursière d'XOMA Royalty est de US$298,81 million. XOMA Royalty a un ratio cours/bénéfice (ratio PE) de -7.35.

XOMAO Dernières nouvelles

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

 EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following...

XOMA Royalty to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and Rezolute Expanded the commercial royalty and milestone portfolio with the...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

XOMAO - Frequently Asked Questions (FAQ)

What is the current XOMA Royalty share price?
The current share price of XOMA Royalty is US$ 25,30
How many XOMA Royalty shares are in issue?
XOMA Royalty has 11 782 723 shares in issue
What is the market cap of XOMA Royalty?
The market capitalisation of XOMA Royalty is USD 298,81M
What is the 1 year trading range for XOMA Royalty share price?
XOMA Royalty has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of XOMA Royalty?
The price to earnings ratio of XOMA Royalty is -7,35
What is the cash to sales ratio of XOMA Royalty?
The cash to sales ratio of XOMA Royalty is 63,08
What is the reporting currency for XOMA Royalty?
XOMA Royalty reports financial results in USD
What is the latest annual turnover for XOMA Royalty?
The latest annual turnover of XOMA Royalty is USD 4,76M
What is the latest annual profit for XOMA Royalty?
The latest annual profit of XOMA Royalty is USD -40,83M
What is the registered address of XOMA Royalty?
The registered address for XOMA Royalty is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the XOMA Royalty website address?
The website address for XOMA Royalty is www.xoma.com
Which industry sector does XOMA Royalty operate in?
XOMA Royalty operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SFHGSamfine Creation Holdings Group Ltd
US$ 1,23
(23,00%)
2M
AVNWAviat Networks Inc
US$ 24,25
(18,00%)
20,18k
AVLDirexion Daily AVGO Bull 2X Shares
US$ 33,15
(10,17%)
68,15k
AVGXDefiance Daily Target 2X Long AVGO ETF
US$ 30,61
(9,87%)
122,43k
CRUSCirrus Logic Inc
US$ 110,5472
(9,03%)
40,39k
INTAIntapp Inc
US$ 60,00
(-18,38%)
50,51k
SDASunCar Technology Group Inc
US$ 8,51
(-17,38%)
28,59k
GGLLDirexion Daily GOOGL Bull 2X ETF
US$ 45,80
(-14,07%)
630,09k
EYENEyenovia Inc
US$ 2,46
(-9,89%)
233,21k
LTRYLottery com Inc
US$ 0,5309
(-9,65%)
1,07M
AMDAdvanced Micro Devices Inc
US$ 114,25
(-4,39%)
8,68M
CYNCYNGN Inc
US$ 0,0769
(8,31%)
7,54M
GOOGLAlphabet Inc
US$ 191,67
(-7,13%)
5,77M
AMDLGraniteShares 2X Long AMD Daily ETF
US$ 6,66
(-8,89%)
5,67M
NVDANVIDIA Corporation
US$ 119,34
(0,58%)
5,46M
Aucune Discussion Trouvée
Ajouter une Discussion